1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Epigenetix, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies EP31670 - Castrate Resistant Prostate Cancer, NUT Carcinoma | Phase 1 | Unknown | Epigenetix, Inc. | 75 | 2022-12-21 | 2025-01-14 |
Leukemia, Myelomonocytic, Chronic (1) · Primary Myelofibrosis (1)
NEO2734 (1)
United States (1)
Judy Chiao, MD (1)